Impact of Disease History on the Efficacy of Ritlecitinib (PF-06651600) in Patients With Alopecia Areata: Post Hoc Analysis of the ALLEGRO Phase 2b/3 Study
Main Article Content
Keywords
alopecia areata, efficacy, ritlecitinib, ALLEGRO, clinical trial
References
1. Islam N, et al. Autoimmun Rev. 2015;14:81-89
2. King B, et al. Poster presented at: 30th Annual EADV Meeting; September 29-October 2, 2021
3. Liu LY, et al. JAAD. 2017;76:22-28
4. King BA, et al. JAAD. 2022;86:359-364
5. Meah N, et al. JAAD. 2021;84:1594-1601.
2. King B, et al. Poster presented at: 30th Annual EADV Meeting; September 29-October 2, 2021
3. Liu LY, et al. JAAD. 2017;76:22-28
4. King BA, et al. JAAD. 2022;86:359-364
5. Meah N, et al. JAAD. 2021;84:1594-1601.